Vardenafil: Clinical Trials

18 trials of Vardenafil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 unknown, 2 terminated, 1 temporarily not available. 7 Phase 4, 5 Phase 2, 3 Phase 1, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 47Unknown 4, Completed 3
Phase 25Completed 4, Terminated 1
Phase 13Completed 3
Phase 32Completed 2
Early Phase 11Terminated 1

Follow Vardenafil: new trials by email Literature Review of Vardenafil trials Research Report on Vardenafil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn
Vardenafil, Sildenafil - PPHN
Phase 1 / Phase 2CompletedDamascus University552023-05-012025-03-06
Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis
Vardenafil, HVPG (Hepatic venous pressure measurement) baseline, HVPG (Hepatic venous pressure measurement) day 7 - Cirrhosis, Erectile Dysfunction
Phase 4UnknownMedical University of Vienna302012-06-012015-09-25
Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases
Vardenafil, Carboplatin - Glioma, Brain Neoplasms
Early Phase 1TerminatedCedars-Sinai Medical Center72012-03-272017-09-11
Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)
Vardenafil, CBST - Erectile Dysfunction
Phase 4CompletedUniversity of Florence302012-03-012018-10-16
Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?
Vardenafil, Placebo - Cystic Fibrosis
Phase 2TerminatedCliniques universitaires Saint-Luc- Université Catholique de Louvain52011-10-012019-02-25
The Safety of Vardenafil in Patients Undergoing Cardiac Surgery
Vardenafil - Ischemia-reperfusion Injury.
Phase 1CompletedMcGuire Research Institute102010-12-012011-11-04
Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors
BAY60-4552 plus Vardenafil, Vardenafil, Placebo - Erectile Dysfunction
Phase 2CompletedBayer1402010-08-012014-11-04
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
PDE5 Inhibitors - Nonarteritic Anterior Ischemic Optic Neuropathy
CompletedEli Lilly and Company3452010-05-012018-04-05
Diabetes & Vardenafil
Vardenafil, Placebo - Type 2 Diabetes Mellitus (T2DM), Endothelial Dysfunction
Phase 2CompletedAzienda USL Modena542010-03-012014-08-19
Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction
Vardenafil - Erectile Dysfunction, Arterial Hypertension
Phase 4CompletedHospital Universitario Pedro Ernesto1002010-01-012011-04-18
Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
Tadalafil, Vardenafil - Pulmonary Arterial Hypertension
Phase 4UnknownRabin Medical Center302008-08-012008-06-26
A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury
Vardenafil, Placebo - Erectile Dysfunction
Phase 4UnknownChina Rehabilitation Research Center3502008-08-012008-07-30
The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
Vardenafil, Placebo - Pulmonary Hypertension
Phase 3CompletedTongji University602008-07-012010-02-12
Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc
Maraviroc, Vardenafil, Placebo - AIDS
Phase 4CompletedViiV Healthcare182008-04-012013-01-25
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
phosphodiesterase type 5 inhibitor - Pharmacokinetics of Three PDE5Is, Healthy Subjects
Phase 1CompletedInje University212007-12-012008-10-07
Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i
Sildenafil, Vardenafil, Sildenafil, Vardenafil - Impotence
Phase 4UnknownRambam Health Care Campus462007-03-012010-10-22
Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
vardenafil, Placebo - Raynaud Syndrome
Phase 2 / Phase 3CompletedUniversity of Cologne572006-11-012011-02-08
Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease
Vardenafil, Placebo - Therapy Refractory Myocardial Ischemia, Coronary Artery Disease
Temporarily not availableMedical University of Vienna2011-08-01

Conditions studied

Erectile Dysfunction (7)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Brain Neoplasms (1)  ·  Coronary Artery Disease (1)  ·  Cystic Fibrosis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fibrosis (1)  ·  Glioma (1)  ·  Hypertension (1)  ·  Hypertension, Portal (1)  ·  Hypertension, Pulmonary (1)  ·  Optic Neuropathy, Ischemic (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Raynaud Disease (1)  ·  Reperfusion Injury (1)

Sponsors

Medical University of Vienna (2)  ·  Azienda USL Modena (1)  ·  Bayer (1)  ·  Cedars-Sinai Medical Center (1)  ·  China Rehabilitation Research Center (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Damascus University (1)  ·  Eli Lilly and Company (1)  ·  Hospital Universitario Pedro Ernesto (1)  ·  Inje University (1)  ·  McGuire Research Institute (1)  ·  Rabin Medical Center (1)  ·  Rambam Health Care Campus (1)  ·  Tongji University (1)  ·  University of Cologne (1)

Countries

Italy (3)  ·  United States (3)  ·  Austria (2)  ·  Belgium (2)  ·  China (2)  ·  Germany (2)  ·  Israel (2)  ·  Brazil (1)  ·  Finland (1)  ·  France (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  Syria (1)

Top investigators

Arnulf Ferlitsch, MD (1)  ·  Ilan Gruenwald, MD (1)  ·  Ion Jovin, MD (1)  ·  Jae-Gook Shin (1)  ·  Li-Min Liao, Dr. (1)  ·  Manuela Simoni, MD, PhD (1)  ·  Mario F Neves, MD, PhD. (1)  ·  Mario Maggi (1)  ·  Mordechai R Kramer, MD (1)  ·  Stephan Rosenkranz, MD (1)

Results publications

PMID 15618584, PMID 18006891, PMID 26311340

NIH funding

2005 (1)